PPLPHARMA.NS Profit & Loss

Piramal Pharma Ltd.

Profit & Loss · 4 years on file (FY2022-23 to FY2025-26) · fetched 2026-08-23 23:43

Line item	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹70.82 Bn	₹81.71 Bn	₹91.51 Bn	₹88.69 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	N/A	N/A	N/A	N/A	SegmentRevenueFromOperations
Other Income	₹2.25 Bn	₹1.75 Bn	₹1.35 Bn	₹2.13 Bn	OtherIncome
Total Income	₹73.07 Bn	₹83.47 Bn	₹92.86 Bn	₹90.82 Bn	Income
Cost of Materials Consumed	₹16.82 Bn	₹19.77 Bn	₹20.56 Bn	₹19.96 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹9.52 Bn	₹11.76 Bn	₹14.17 Bn	₹14.31 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹0.69 Bn	₹-1.99 Bn	₹-2.41 Bn	₹-1.88 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹18.96 Bn	₹20.30 Bn	₹23.07 Bn	₹24.16 Bn	EmployeeBenefitExpense
Finance Costs	₹3.44 Bn	₹4.48 Bn	₹4.22 Bn	₹3.41 Bn	FinanceCosts
Depreciation and Amortisation	₹6.77 Bn	₹7.41 Bn	₹8.16 Bn	₹8.31 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹18.54 Bn	₹19.91 Bn	₹21.67 Bn	₹22.93 Bn	OtherExpenses
Total Expenses	₹74.74 Bn	₹81.64 Bn	₹89.44 Bn	₹91.19 Bn	Expenses
Profit Before Exceptional Items and Tax	₹-1.68 Bn	₹1.83 Bn	₹3.42 Bn	₹-0.37 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹-0.07 Bn	₹-0.63 Bn	₹0.00 Bn	₹-1.96 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹-1.74 Bn	₹1.20 Bn	₹3.42 Bn	₹-2.33 Bn	ProfitBeforeTax
Tax Expense	₹0.66 Bn	₹1.61 Bn	₹3.24 Bn	₹1.50 Bn	TaxExpense
Net Profit (incl. minority interest)	₹-1.86 Bn	₹0.18 Bn	₹0.91 Bn	₹-3.26 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	N/A	N/A	₹0.91 Bn	₹-3.26 Bn	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹-1.57	₹0.14	₹0.69	₹-2.46	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹-1.57	₹0.14	₹0.68	₹-2.46	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from PPLPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).